Trial Profile
Efficacy of CT-P13 in Patients with inflammatory bowel disease : a prospective, observational study
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 21 Sep 2017
Price :
$35
*
At a glance
- Drugs Infliximab (Primary)
- Indications Crohn's disease; Ulcerative colitis
- Focus Therapeutic Use
- 21 Sep 2017 New trial record